| Item | Current | Prior | YoY % |
|---|---|---|---|
| Net Sales | ¥30.64B | ¥31.36B | -2.3% |
| Cost of Sales | ¥26.61B | ¥27.16B | -2.0% |
| Gross Profit | ¥4.03B | ¥4.21B | -4.1% |
| SG&A Expenses | ¥3.82B | ¥3.68B | +3.7% |
| Operating Income | ¥216M | ¥522M | -58.6% |
| Non-operating Income | ¥99M | ¥40M | +147.5% |
| Non-operating Expenses | ¥18M | ¥9M | +100.0% |
| Ordinary Income | ¥297M | ¥552M | -46.2% |
| Profit Before Tax | ¥295M | ¥586M | -49.7% |
| Income Tax Expense | ¥162M | ¥249M | -34.9% |
| Net Income | ¥133M | ¥337M | -60.5% |
| Net Income Attributable to Owners | ¥134M | ¥338M | -60.4% |
| Total Comprehensive Income | ¥107M | ¥392M | -72.7% |
| Depreciation & Amortization | ¥93M | ¥88M | +5.7% |
| Interest Expense | ¥2M | ¥1M | +100.0% |
| Earnings per Unit (EPU) | ¥53.28 | ¥136.80 | -61.1% |
| Distribution per Unit (DPU) | ¥0.00 | ¥0.00 | - |
| Item | Current End | Prior End | Change |
|---|---|---|---|
| Current Assets | ¥19.72B | ¥21.77B | ¥-2.04B |
| Cash and Deposits | ¥3.31B | ¥5.70B | ¥-2.39B |
| Accounts Receivable | ¥11.66B | ¥12.21B | ¥-550M |
| Inventories | ¥4.08B | ¥3.15B | +¥929M |
| Non-current Assets | ¥6.24B | ¥5.78B | +¥455M |
| Item | Current | Prior | Change |
|---|---|---|---|
| Operating Cash Flow | ¥-1.44B | ¥-633M | ¥-806M |
| Investing Cash Flow | ¥-615M | ¥19M | ¥-634M |
| Financing Cash Flow | ¥-337M | ¥-239M | ¥-98M |
| Free Cash Flow | ¥-2.05B | - | - |
| Item | Value |
|---|---|
| Net Profit Margin | 0.4% |
| Gross Profit Margin | 13.2% |
| Current Ratio | 119.1% |
| Quick Ratio | 94.5% |
| Debt-to-Equity Ratio | 1.91x |
| Interest Coverage Ratio | 108.00x |
| EBITDA Margin | 1.0% |
| Effective Tax Rate | 54.9% |
| Item | YoY Change |
|---|---|
| Net Sales YoY Change | -2.3% |
| Operating Income YoY Change | -58.6% |
| Ordinary Income YoY Change | -46.1% |
| Net Income Attributable to Owners YoY Change | -60.3% |
| Total Comprehensive Income YoY Change | -72.5% |
| Item | Value |
|---|---|
| Units Outstanding (incl. Treasury) | 2.55M shares |
| Treasury Units | 61K shares |
| Average Units Outstanding | 2.52M shares |
| NAV per Unit | ¥3,576.02 |
| EBITDA | ¥309M |
| Item | Amount |
|---|---|
| Q2 Distribution | ¥0.00 |
| Year-End Distribution | ¥75.00 |
| Segment | Revenue | Operating Income |
|---|---|---|
| MedicalEquipmentSales | ¥30.50B | ¥834M |
| MedicalMall | ¥36M | ¥4M |
| Item | Forecast |
|---|---|
| Net Sales Forecast | ¥67.65B |
| Operating Income Forecast | ¥590M |
| Ordinary Income Forecast | ¥632M |
| Net Income Attributable to Owners Forecast | ¥354M |
| Earnings per Unit Forecast (EPU) | ¥143.58 |
| Distribution per Unit Forecast (DPU) | ¥70.00 |
| Property, Plant & Equipment | ¥3.76B | ¥3.38B | +¥386M |
| Intangible Assets | ¥360M | ¥374M | ¥-14M |
| Goodwill | ¥270M | ¥293M | ¥-23M |
| Investment Securities | ¥1.14B | ¥1.14B | +¥3M |
| Total Assets | ¥25.96B | ¥27.55B | ¥-1.59B |
| Current Liabilities | ¥16.56B | ¥18.09B | ¥-1.53B |
| Accounts Payable | ¥8.42B | ¥8.58B | ¥-160M |
| Non-current Liabilities | ¥493M | ¥472M | +¥21M |
| Total Liabilities | ¥17.05B | ¥18.56B | ¥-1.51B |
| Total Equity | ¥8.91B | ¥8.99B | ¥-76M |
| Capital Stock | ¥494M | ¥494M | ¥0 |
| Capital Surplus | ¥594M | ¥627M | ¥-33M |
| Retained Earnings | ¥7.16B | ¥7.21B | ¥-51M |
| Treasury Stock | ¥-186M | ¥-231M | +¥45M |
| Owners' Equity | ¥8.91B | ¥8.98B | ¥-64M |
| Working Capital | ¥3.17B | - | - |